Acutus Medical (NASDAQ:AFIB) Trading Up 7.9%

Shares of Acutus Medical, Inc. (NASDAQ:AFIBGet Rating) were up 7.9% on Thursday . The company traded as high as $0.68 and last traded at $0.68. Approximately 42,762 shares changed hands during trading, a decline of 97% from the average daily volume of 1,427,386 shares. The stock had previously closed at $0.63.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on AFIB shares. BTIG Research boosted their target price on Acutus Medical to $2.50 in a report on Monday, August 15th. The Goldman Sachs Group restated a “neutral” rating and issued a $1.50 price target on shares of Acutus Medical in a research note on Tuesday, August 16th. Four research analysts have rated the stock with a hold rating and one has given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $2.33.

Acutus Medical Price Performance

The company has a debt-to-equity ratio of 0.59, a quick ratio of 4.33 and a current ratio of 5.12. The company has a market cap of $19.35 million, a price-to-earnings ratio of -0.22 and a beta of 1.03. The business has a fifty day moving average price of $0.82 and a 200 day moving average price of $0.96.

Hedge Funds Weigh In On Acutus Medical

A number of institutional investors have recently modified their holdings of AFIB. Vanguard Group Inc. raised its holdings in shares of Acutus Medical by 70.1% during the 3rd quarter. Vanguard Group Inc. now owns 1,142,170 shares of the company’s stock worth $1,005,000 after buying an additional 470,719 shares in the last quarter. GSA Capital Partners LLP increased its holdings in Acutus Medical by 461.4% in the 1st quarter. GSA Capital Partners LLP now owns 481,303 shares of the company’s stock worth $669,000 after purchasing an additional 395,576 shares in the last quarter. Granite Point Capital Management L.P. acquired a new position in Acutus Medical in the 1st quarter worth about $499,000. Renaissance Technologies LLC acquired a new position in Acutus Medical in the 1st quarter worth about $499,000. Finally, Clear Street LLC acquired a new position in Acutus Medical in the 2nd quarter worth about $202,000. Institutional investors and hedge funds own 74.58% of the company’s stock.

About Acutus Medical

(Get Rating)

Acutus Medical, Inc, an arrhythmia management company, designs, manufactures, and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. The company's product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs.

Featured Articles

Receive News & Ratings for Acutus Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acutus Medical and related companies with MarketBeat.com's FREE daily email newsletter.